2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
3
Ovarian Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Stomach Neoplasms
1
Stereotactic Body Radiation Therapy
1
Radiation Pneumonitis
1
Brain Neoplasms
1
Advanced Non-squamous Non-small Cell Lung Cancer
1
Adenocarcinoma of Lung
1
Interventions
anlotinib
1
Chemotherapy, Adjuvant
1
Angiogenesis Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stereotactic Body Radiation Therapy
×
Angiogenesis Inhibitors
×
Clear all
NCT04912128
2021-06-03
AnloSBRT
Peking University Third Hospital
Completed
30 enrolled